Risperidone Exacerbates Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Renal Impairment in Obese Mice

Risperidone, a second-generation antipsychotic drug used for schizophrenia treatment with less-severe side effects, has recently been applied in major depressive disorder treatment. The mechanism underlying risperidone-associated metabolic disturbances and liver and renal adverse effects warrants fu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Mol Sci
Main Authors: Tsai, Hsiao-Pei, Hou, Po-Hsun, Mao, Frank-Chiahung, Chang, Chia-Chia, Yang, Wei-Cheng, Wu, Ching-Feng, Liao, Huei-Jyuan, Lin, Tzu-Chun, Chou, Lan-Szu, Hsiao, Li-Wei, Chang, Geng-Ruei
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7795724/
https://ncbi.nlm.nih.gov/pubmed/33401717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22010409
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados